Moleculin Biotech, Inc.

MBRX

Moleculin Biotech, Inc.

MBRX

Insider Sentiment (TTM):

Last Purchase:2025-06-23Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:138,402Shares Outstanding:4,124,482Institutional Ownership Pct.:3.36%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	7	10	9	7	8	8	4	9	11	17	24	25
Assets Current
Assets Current	9	11	10	8	9	9	5	12	14	19	26	28
Prepaid Expense And Other Assets Current	1	1	1	1	2	2	1	2	3	2	3	3
Intangible Assets Net Including Goodwill	11	11	11	11	11	11	11	11	11	11	11	11
Other Assets Noncurrent	1	1	1	1	1	-	0	-	-	-	-	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	1	1	1
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets	21	23	22	20	22	21	17	23	26	31	38	40
Accounts Payable Current	4	5	4	2	4	3	2	3	3	2	2	2
Liabilities Current
Liabilities Current	9	8	7	6	8	7	5	6	6	5	7	4
Accrued Liabilities Current	5	3	3	4	4	4	3	3	3	3	4	2
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Derivative Liabilities Noncurrent	0	0	0	41	21	14	0	10	2	3	5	0
Liabilities	10	8	7	47	29	21	6	16	8	9	12	4
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	238	234	221	195	160	160	184	159	159	158	158	156
Stockholders Equity
Aoci Before Tax Attributable To Parent	-	-	-	-0	-0	-0	-0	0	-0	-0	-0	-0
Stockholders Equity	12	15	15	-27	-0	14	11	17	18	22	26	35
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	-	-	-	-0	-	-	-	-	-
Retained Earnings Accumulated Deficit	-226	-219	-206	-222	-167	-160	-172	-151	-141	-137	-132	-121
Accumulated Depreciation Depletion And Amortizatio…	-	-	1	-	-	-	1	-	-	-	1	-
Liabilities And Stockholders Equity	21	23	22	20	22	21	17	23	26	31	38	40
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	100	100	100	100	100	100	100	100
Common Stock Shares Issued	7	5	3	2	1	1	0	0	0	0	0	0
Shares Outstanding	7	5	3	2	1	1	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	9.09%	20.00%	-81.82%	-	-	-	-	-	-	-	-	-
2025	-37.38%	-68.22%	-37.85%	-43.35%	-30.21%	-29.76%	-36.21%	-68.11%	-62.20%	25.96%	18.75%	15.38%
2024	0.21%	-26.05%	-26.05%	2.13%	0.43%	4.26%	8.63%	-35.29%	-33.33%	-26.61%	-3.67%	-38.53%
2023	-	-	-	-	-	-	-4.51%	45.83%	-11.98%	-18.90%	-16.56%	-24.28%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.94	1.38	1.41	1.39	1.15	1.35	0.97	2.08	2.39	3.51	3.86	7.10
Quick Ratio	0.78	1.30	1.30	1.18	0.96	1.12	0.80	1.68	1.89	3.11	3.46	6.32
Working Capital	-590.00K	3.00M	2.83M	2.20M	1.16M	2.44M	-165.00K	6.01M	7.99M	13.55M	19.46M	23.72M
Leverage & Debt
Debt to Equity	0.82	0.54	0.47	-1.76	-8,021.76	1.52	0.51	0.91	0.44	0.43	0.47	0.12
Interest Coverage TTM	-179.35	-248.02	-239.08	-169.32	-123.50	-76.42	-48.44	-37.85	-28.12	-22.97	-21.66	-22.53
Debt Ratio	0.45	0.35	0.32	2.32	1.33	1.00	0.34	0.68	0.31	0.30	0.32	0.11
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Free Cash Flow Per Share TTM	-4.46	-5.89	-19.19	-15.05	-34.36	-58.12	-173.36	-159.99	-248.07	-247.50	-300.10	-326.99
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-19.64%	57.03%	29.24%	121.38%	60.81%	0.59%	-12.50%	1.19%	-14.02%	-10.80%	2.56%	4.74%
EPS Growth (1Y)	-91.21%	-85.77%	-84.97%	-77.96%	-73.66%	-73.45%	-49.79%	-45.86%	-33.09%	-30.68%	-1.00%	0.64%
Valuation Metrics
P/E TTM	-0.49	-0.22	-0.12	-0.34	-0.12	-0.34	-0.22	-0.40	-0.36	-0.54	-0.85	-0.49
P/B TTM	1.37	0.62	0.26	-0.73	-1,307.94	0.66	0.52	0.61	0.51	0.68	0.98	0.36
Market Cap	15.85M	9.45M	3.92M	19.77M	4.69M	9.10M	5.85M	10.55M	8.95M	14.58M	25.43M	12.76M
Enterprise Value	8.59M	-871.94K	-4.96M	13.07M	-2.87M	1.38M	1.58M	1.14M	-1.89M	-2.25M	1.88M	-11.82M
Calculated Values
Free Cash Flow TTM	-25.36M	-24.28M	-22.74M	-22.45M	-21.34M	-21.72M	-23.88M	-23.77M	-25.24M	-24.42M	-23.72M	-25.99M
Net Debt	-7.26M	-10.32M	-8.88M	-6.70M	-7.56M	-7.72M	-4.28M	-9.41M	-10.85M	-16.82M	-23.55M	-24.58M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-06-23Purchase

Owner: Klemp, Walter V

Title: CEO and President

Shares: 675,675

Price/Share: $0.37

Value: $249,999.75

Shares Owned: 743,607

Relationship: Director,Officer

Ownership: Direct

2025-06-23Purchase

Owner: Foster, Jonathan P.

Title: Chief Financial Officer

Shares: 270,270

Price/Share: $0.37

Value: $99,999.90

Shares Owned: 287,587

Relationship: Officer

Ownership: Direct

2023-12-26Purchase

Owner: George, Robert E.

Title: -

Shares: 14,493

Price/Share: $0.69

Value: $10,000.17

Shares Owned: 14,660

Relationship: Director

Ownership: Direct

2023-12-26Purchase

Owner: Foster, Jonathan P.

Title: Chief Financial Officer

Shares: 28,986

Price/Share: $0.69

Value: $20,000.34

Shares Owned: 80,556

Relationship: Officer

Ownership: Direct

2023-12-26Purchase

Owner: Klemp, Walter V

Title: CEO and President

Shares: 188,404

Price/Share: $0.69

Value: $129,998.76

Shares Owned: 680,880

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-06-23	Klemp, Walter V	Director,Officer	CEO and President	Direct	Purchase	675,675	0.37	$249,999.75	743,607	4
2025-06-23	Foster, Jonathan P.	Officer	Chief Financial Officer	Direct	Purchase	270,270	0.37	$99,999.90	287,587	4
2023-12-26	George, Robert E.	Director	-	Direct	Purchase	14,493	0.69	$10,000.17	14,660	4
2023-12-26	Foster, Jonathan P.	Officer	Chief Financial Officer	Direct	Purchase	28,986	0.69	$20,000.34	80,556	4
2023-12-26	Klemp, Walter V	Director,Officer	CEO and President	Direct	Purchase	188,404	0.69	$129,998.76	680,880	4
2022-11-25	Klemp, Walter V	Director,Officer	CEO and President	Direct	Purchase	45,000	1.28	$57,600.00	409,890	4
2022-11-21	Klemp, Walter V	Director,Officer	CEO and President	Direct	Purchase	22,500	1.15	$25,875.00	364,890	4
2022-11-17	Klemp, Walter V	Director,Officer	CEO and President	Direct	Purchase	24,742	1.02	$25,236.84	342,390	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.36%

Inst. Shares: 138,402

Shares Outstanding: 4,124,482

2025-12-31

8.04%

Inst. Shares: 95,220

Shares Outstanding: 1,184,569

2025-09-30

1.74%

Inst. Shares: 650,430

Shares Outstanding: 37,304,455

2025-06-30

2.32%

Inst. Shares: 360,672

Shares Outstanding: 15,526,401

2025-03-31

Inst. Shares: 1,465,263

Shares Outstanding: 373,751

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	138,402	4,124,482	3.36%
2025-12-31	95,220	1,184,569	8.04%
2025-09-30	650,430	37,304,455	1.74%
2025-06-30	360,672	15,526,401	2.32%
2025-03-31	1,465,263	373,751	-
2024-12-31	464,650	137,720	-
2024-09-30	460,563	3,714,278	12.40%
2024-06-30	312,355	2,543,244	12.28%
2024-03-31	258,450	2,466,174	10.48%
2023-12-31	5,054,047	1,975,610	255.82%
2023-09-30	2,031,969	1,987,283	102.25%
2023-06-30	2,158,224	1,979,258	109.04%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Moleculin Biotech, Inc. (MBRX) — SEC Financial Statements & Analysis

Moleculin Biotech, Inc. (MBRX) is a pharmaceutical preparations company, incorporated in DE. Moleculin Biotech, Inc. trades on Nasdaq as: MBRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Moleculin Biotech, Inc. reported a Debt-to-Equity ratio of 0.82x, a Price-to-Book (P/B) ratio of 1.37x (TTM), at a market cap of $15.85M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.82x
P/B TTM: 1.37x
Market Cap: $15.85M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Moleculin Biotech, Inc. in?

Moleculin Biotech, Inc. (MBRX) operates in the Pharmaceutical Preparations industry.

What is MBRX's market cap?

Moleculin Biotech, Inc. (MBRX) has a market capitalization of $15.85M as of 2026-06-30.

What exchange does MBRX trade on?

Moleculin Biotech, Inc. (MBRX) trades on the Nasdaq.

Where is Moleculin Biotech, Inc. incorporated?

Moleculin Biotech, Inc. is incorporated in DE.